Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8857 - 8864 of 12092 results

Biosimilars Webinars: A Five-Part Legal and Regulatory Issues Series
December 15, 2015| Blog| Viewpoint

Mintz Advisory Analyzes Health Care Qui Tam Litigation Trends
December 15, 2015| Blog| Viewpoint

The Affordable Care Act’s Reporting Requirements for Carriers and Employers (Part 21 of 24): Reporting for “MEC” Plans
December 14, 2015| Blog| Viewpoint

HIPAA and Health Care Data Privacy - 2015 in Review
December 14, 2015| Blog| Viewpoint

FDA Legal and Regulatory – 2015 Year In Review
December 14, 2015| Blog| Viewpoint

Paul Dickerson Shares Insight on Energy M&A Trends
December 14, 2015| Blog| Viewpoint

HIPAA and Health Care Data Privacy – 2015 Year in Review
December 11, 2015| Blog| Viewpoint

Wyndham and FTC Settle Case Over "Unfair" Data Security Practices
December 10, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
